Advertisement.

DTCFF Projected Dividend Yield

Defence Therapeutics Inc ( OTCBB : DTCFF )

Defence Therapeutics is engaged in the research and development of biological/biosimilar therapeutic drugs targeting cancer and infectious diseases. Co.'s Accum technology takes multitude biological/biosimilar-based pharmaceutical to a bold new frontier by enabling efficient intracellular access to a given biological while maintaining target cell specificity. Co.'s product pipeline focuses on the intracellular access by different type of vaccine (DNA, RNA and protein) and by protein-delivery system such as monoclonal antibody-based therapies. The Accum technology platform is being used for both antibody drug conjugates- and vaccine-related projects.

20 YEAR PERFORMANCE RESULTS

DTCFF Dividend History Detail
DTCFF Dividend News
DTCFF Competitors News

# of Shares: 0

Closing Price: 0.98

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000